Agate Pass Investment Management’s American Tower AMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Hold
1,470
0.09% 99
2026
Q1
$254K Hold
1,470
0.1% 94
2025
Q4
$258K Hold
1,470
0.1% 96
2025
Q3
$283K Sell
1,470
-48
-3% -$10K 0.11% 97
2025
Q2
$336K Hold
1,518
0.14% 96
2025
Q1
$330K Sell
1,518
-48
-3% -$9.42K 0.14% 99
2024
Q4
$287K Hold
1,566
0.13% 101
2024
Q3
$364K Hold
1,566
0.18% 79
2024
Q2
$304K Sell
1,566
-25
-2% -$4.67K 0.16% 83
2024
Q1
$314K Hold
1,591
0.17% 81
2023
Q4
$343K Hold
1,591
0.2% 78
2023
Q3
$262K Sell
1,591
-352
-18% -$64.3K 0.18% 77
2023
Q2
$377K Hold
1,943
0.23% 75
2023
Q1
$397K Hold
1,943
0.26% 78
2022
Q4
$412K Hold
1,943
0.29% 75
2022
Q3
$417K Hold
1,943
0.32% 71
2022
Q2
$497K Hold
1,943
0.35% 70
2022
Q1
$488K Hold
1,943
0.3% 69
2021
Q4
$568K Buy
+1,943
New +$531K 0.35% 64

Other funds holding AMT

Agate Pass Investment Management's AMT Position: Q2 2026 in Review

Agate Pass Investment Management held its American Tower (AMT) position steady in Q2 2026 at 1,470 shares worth $240K. The position accounts for 0.09% of the portfolio, ranked #99.

Agate Pass Investment Management first reported a position in AMT in Q4 2021 and has held it in 19 quarters since. The position peaked at $568K in Q4 2021. 351 funds tracked by Wall St. Rank hold AMT as of Q2 2026.

  • Agate Pass Investment Management held 1,470 shares of American Tower worth $240K as of Q2 2026.
  • Agate Pass Investment Management left its American Tower share count unchanged in Q2 2026.
  • American Tower made up 0.09% of Agate Pass Investment Management's portfolio in Q2 2026, its #99 holding.
  • Agate Pass Investment Management first reported a position in American Tower in Q4 2021 and has held it in 19 quarters since.
  • Agate Pass Investment Management's American Tower position peaked at $568K in Q4 2021.
  • 351 funds tracked by Wall St. Rank held American Tower as of Q2 2026.

Based on Agate Pass Investment Management's 13F filing for Q2 2026, filed 8 Jul 2026.